Webinar Date & Time: Tuesday, April 14, 2020 – 1:00pm EST
CMIC Group will be joining Nuventra Pharma Sciences‘ webinar on April 14th at 1:00pm EST for the second live panel discussion on drug development during the COVID-19 pandemic. The panel will have industry experts discuss the latest impacts on Phase 1 clinical trials and how labs are adjusting to the crisis.
Topics will include:
- Regulatory impacts from a former FDA reviewer
- The latest impact on ongoing and planned clinical trials from a Phase 1 site
- How labs are adjusting to the crisis
- FAQs from our clients and colleagues
Register on the Nuventra Pharma Sciences website and join us on April 14, 2020 for this informative drug development discussion: https://www.nuventra.com/resources/events/covid-19-pandemic-panel-discussion-part-2/
